These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 24667101)
1. Characterization of Insulin-Secreting Porcine Bone Marrow Stromal Cells Ex Vivo and Autologous Cell Therapy In Vivo. Do HV; Loke WT; Kee I; Liang V; David SJ; Gan SU; Lee SS; Ng WH; Koong HN; Ong HS; Lee KO; Calne RY; Kon OL Cell Transplant; 2015; 24(7):1205-20. PubMed ID: 24667101 [TBL] [Abstract][Full Text] [Related]
2. Insulin expressed from endogenously active glucose-responsive EGR1 promoter in bone marrow mesenchymal stromal cells as diabetes therapy. Chen NK; Tan SY; Udolph G; Kon OL Gene Ther; 2010 May; 17(5):592-605. PubMed ID: 20182520 [TBL] [Abstract][Full Text] [Related]
3. Nonvirally modified autologous primary hepatocytes correct diabetes and prevent target organ injury in a large preclinical model. Chen NK; Wong JS; Kee IH; Lai SH; Thng CH; Ng WH; Ng RT; Tan SY; Lee SY; Tan ME; Sivalingam J; Chow PK; Kon OL PLoS One; 2008 Mar; 3(3):e1734. PubMed ID: 18320053 [TBL] [Abstract][Full Text] [Related]
4. Beta-cell function and mass in type 2 diabetes. Larsen MO Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971 [TBL] [Abstract][Full Text] [Related]
5. Making surrogate β-cells from mesenchymal stromal cells: perspectives and future endeavors. Bhonde RR; Sheshadri P; Sharma S; Kumar A Int J Biochem Cell Biol; 2014 Jan; 46():90-102. PubMed ID: 24275096 [TBL] [Abstract][Full Text] [Related]
6. Bone marrow-derived mesenchymal stem cells ameliorate chronic high glucose-induced β-cell injury through modulation of autophagy. Zhao K; Hao H; Liu J; Tong C; Cheng Y; Xie Z; Zang L; Mu Y; Han W Cell Death Dis; 2015 Sep; 6(9):e1885. PubMed ID: 26379190 [TBL] [Abstract][Full Text] [Related]
7. Quercetin potentiates transdifferentiation of bone marrow mesenchymal stem cells into the beta cells in vitro. Miladpour B; Rasti M; Owji AA; Mostafavipour Z; Khoshdel Z; Noorafshan A; Zal F J Endocrinol Invest; 2017 May; 40(5):513-521. PubMed ID: 28000178 [TBL] [Abstract][Full Text] [Related]
8. Impact of different pancreatic microenvironments on improvement in hyperglycemia and insulin deficiency in diabetic rats after transplantation of allogeneic mesenchymal stromal cells. Katuchova J; Tothova T; Farkasova Iannaccone S; Toporcer T; Harvanova D; Hildebrand T; Kilik R; Bacenkova D; Frohlichova L; Rosocha J; Bobrov N; Radonak J J Surg Res; 2012 Nov; 178(1):188-95. PubMed ID: 22480834 [TBL] [Abstract][Full Text] [Related]
9. Multiple intravenous infusions of bone marrow mesenchymal stem cells reverse hyperglycemia in experimental type 2 diabetes rats. Hao H; Liu J; Shen J; Zhao Y; Liu H; Hou Q; Tong C; Ti D; Dong L; Cheng Y; Mu Y; Liu J; Fu X; Han W Biochem Biophys Res Commun; 2013 Jul; 436(3):418-23. PubMed ID: 23770360 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of Autologous Bone Marrow-Derived Mesenchymal Stem Cell and Mononuclear Cell Transplantation in Type 2 Diabetes Mellitus: A Randomized, Placebo-Controlled Comparative Study. Bhansali S; Dutta P; Kumar V; Yadav MK; Jain A; Mudaliar S; Bhansali S; Sharma RR; Jha V; Marwaha N; Khandelwal N; Srinivasan A; Sachdeva N; Hawkins M; Bhansali A Stem Cells Dev; 2017 Apr; 26(7):471-481. PubMed ID: 28006991 [TBL] [Abstract][Full Text] [Related]
11. The Generation of Insulin Producing Cells from Human Mesenchymal Stem Cells by MiR-375 and Anti-MiR-9. Jafarian A; Taghikani M; Abroun S; Allahverdi A; Lamei M; Lakpour N; Soleimani M PLoS One; 2015; 10(6):e0128650. PubMed ID: 26047014 [TBL] [Abstract][Full Text] [Related]
13. Transplantation of insulin-producing cells differentiated from human periosteum-derived progenitor cells ameliorate hyperglycemia in diabetic mice. Dao LT; Park EY; Lim SM; Choi YS; Jung HS; Jun HS Transplantation; 2014 Nov; 98(10):1040-7. PubMed ID: 25208321 [TBL] [Abstract][Full Text] [Related]
14. Human bone marrow-derived mesenchymal cells differentiate and mature into endocrine pancreatic lineage in vivo. Phadnis SM; Joglekar MV; Dalvi MP; Muthyala S; Nair PD; Ghaskadbi SM; Bhonde RR; Hardikar AA Cytotherapy; 2011 Mar; 13(3):279-93. PubMed ID: 21039304 [TBL] [Abstract][Full Text] [Related]
15. [Treatment of type 1 diabetes by transplantation of bone-derived mesenchymal stem cells expressing human insulin gene: experiment with mice]. Xu J; Zhu MY; Lu YH; Lu Y; Wang ZW Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(36):2557-60. PubMed ID: 18067833 [TBL] [Abstract][Full Text] [Related]
16. Combinatorial human progenitor cell transplantation optimizes islet regeneration through secretion of paracrine factors. Bell GI; Meschino MT; Hughes-Large JM; Broughton HC; Xenocostas A; Hess DA Stem Cells Dev; 2012 Jul; 21(11):1863-76. PubMed ID: 22309189 [TBL] [Abstract][Full Text] [Related]
17. Ex vivo expansion and in vivo infusion of bone marrow-derived Flk-1+CD31-CD34- mesenchymal stem cells: feasibility and safety from monkey to human. Liu L; Sun Z; Chen B; Han Q; Liao L; Jia M; Cao Y; Ma J; Sun Q; Guo M; Liu Z; Ai H; Zhao RC Stem Cells Dev; 2006 Jun; 15(3):349-57. PubMed ID: 16846373 [TBL] [Abstract][Full Text] [Related]
18. Systemic delivery of human growth hormone or human factor IX in dogs by reintroduced genetically modified autologous bone marrow stromal cells. Hurwitz DR; Kirchgesser M; Merrill W; Galanopoulos T; McGrath CA; Emami S; Hansen M; Cherington V; Appel JM; Bizinkauskas CB; Brackmann HH; Levine PH; Greenberger JS Hum Gene Ther; 1997 Jan; 8(2):137-56. PubMed ID: 9017418 [TBL] [Abstract][Full Text] [Related]